Onconetix, Inc. Convertible Notes Payable, Current
Onconetix, Inc. (ONCO) had Convertible Notes Payable, Current of $12.92 million as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-11-17
- 2023-09-30: Convertible Notes Payable, Current $12.92M.
- 2023-06-30: Convertible Notes Payable, Current $8.62M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2023-09-30 | $12.92M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $8.62M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |